Coherus BioSciences
| Region | Nordamerika |
| ISIN | US19249H1032 |
| Sektor | Biotechnologie |
| Website | https://www.coherus.com/ |
Coherus BioSciences is a leading developer of high-quality biosimilar therapeutics.
| Titel | Autor | Datum |
|---|---|---|
|
Milliardenmarkt Biosimilars
8 Kommentare |
Harry1 | translation missing: de.datetime.time_ago_in_words.almost_x_years |
| Titel | Datum |
|---|---|
| Coherus Oncology beruft Arvind Sood zum Chief Strategy and Corporate Affairs Officer | vor ungefähr 2 Monaten |
|
Coherus Oncology, Inc.: Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
- Responsible for Corporate Development, Investor Relations, Government Affairs - REDWOOD CITY, ... |
vor ungefähr 2 Monaten |
| Coherus BioSciences' Earnings Outlook | vor ungefähr 2 Monaten |
| Coherus Oncology, Inc.: Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 | vor ungefähr 2 Monaten |
| Coherus Oncology, Inc.: Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Can... | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Coca-Cola (1 Artikel) | |
| Cisco Systems (1 Artikel) | |
| Commerzbank (1 Artikel) | |
| Contact Gold (2 Artikel) | |
| Alle anzeigen | |